Through our research programs, we are addressing the barriers that are preventing safer treatments from reaching children. Our research strategy encompasses programs and funding that deliver results to save children NOW.
The third and final phase of CureSearch’s research strategy is the Catapult Awards program. These critical awards push forward high-potential research into clinical trials and ultimately drug development.
Catapult Research Awards
Through Catapult Awards, we push high-potential clinical research through the final stages and into the hands of kids who need it the most.
CureSearch won't stop until more and less-toxic children's cancer treatments are out of the lab and into the clinic and marketplace, ensuring more children live long, healthy and productive lives.
For more information on Catapult Awards, developing resources or future RFAs, contact:
National Director, Business Development
Sarita Sastry, PhD
National Director, Research and Programs